Factors affecting treatment compliance in new hypertensive patients in Korea

Hyun Jin Kim, Kanghee Moon, Tae Hee Park, So Youn Park, Seok-Jun Yoon, In Hwan Oh

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

This study aims to analyze continuity of care according to complications and examine the relationship between the continuity of care and health outcomes (hospitalization, emergency department visits, and complications) using data of new hypertensive patients from Korea’s National Health Insurance Claims database. There were a total of 715,053 new hypertensive patients followed up for three years until 2011. Indices of continuity of care were Continuity of Care Index (COC), Modified, Modified Continuity Index (MMCI), and Most Frequent Provider Continuity (MFPC). The mean values of COC, MMCI, and MFPC were 0.79, 0.77, and 0.87, respectively, in new hypertensive patients with complications, and 0.80, 0.79, and 0.87, respectively, in those without complications. The factors affecting the continuity of care were sex, ambulatory care visits, number of providers, main medical institution, and Charlson’s comorbidity score. Following analysis of the correlation between the treatment compliance and health outcomes, the low COC group had a higher association with hospitalization, the emergency department visit, and complications as compared with the high COC group. COC and medication adherence were associated with a reduction of hospitalization, emergency department visits, and complications. This indicates it would be mandatory to manage the patients’ continuity of care.

Original languageEnglish
Pages (from-to)701-709
Number of pages9
JournalClinical and Experimental Hypertension
Volume38
Issue number8
DOIs
Publication statusPublished - 2016 Nov 16

Fingerprint

Continuity of Patient Care
Korea
Therapeutics
Hospital Emergency Service
Hospitalization
Medication Adherence
Health
National Health Programs
Ambulatory Care
Comorbidity
Databases

Keywords

  • cardio-cerebrovascular diseases
  • Continuity of care
  • hypertension
  • Korea
  • treatment compliance

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology

Cite this

Factors affecting treatment compliance in new hypertensive patients in Korea. / Kim, Hyun Jin; Moon, Kanghee; Park, Tae Hee; Park, So Youn; Yoon, Seok-Jun; Oh, In Hwan.

In: Clinical and Experimental Hypertension, Vol. 38, No. 8, 16.11.2016, p. 701-709.

Research output: Contribution to journalArticle

Kim, Hyun Jin ; Moon, Kanghee ; Park, Tae Hee ; Park, So Youn ; Yoon, Seok-Jun ; Oh, In Hwan. / Factors affecting treatment compliance in new hypertensive patients in Korea. In: Clinical and Experimental Hypertension. 2016 ; Vol. 38, No. 8. pp. 701-709.
@article{5be7a576d4854d838b1f11ea08c38730,
title = "Factors affecting treatment compliance in new hypertensive patients in Korea",
abstract = "This study aims to analyze continuity of care according to complications and examine the relationship between the continuity of care and health outcomes (hospitalization, emergency department visits, and complications) using data of new hypertensive patients from Korea’s National Health Insurance Claims database. There were a total of 715,053 new hypertensive patients followed up for three years until 2011. Indices of continuity of care were Continuity of Care Index (COC), Modified, Modified Continuity Index (MMCI), and Most Frequent Provider Continuity (MFPC). The mean values of COC, MMCI, and MFPC were 0.79, 0.77, and 0.87, respectively, in new hypertensive patients with complications, and 0.80, 0.79, and 0.87, respectively, in those without complications. The factors affecting the continuity of care were sex, ambulatory care visits, number of providers, main medical institution, and Charlson’s comorbidity score. Following analysis of the correlation between the treatment compliance and health outcomes, the low COC group had a higher association with hospitalization, the emergency department visit, and complications as compared with the high COC group. COC and medication adherence were associated with a reduction of hospitalization, emergency department visits, and complications. This indicates it would be mandatory to manage the patients’ continuity of care.",
keywords = "cardio-cerebrovascular diseases, Continuity of care, hypertension, Korea, treatment compliance",
author = "Kim, {Hyun Jin} and Kanghee Moon and Park, {Tae Hee} and Park, {So Youn} and Seok-Jun Yoon and Oh, {In Hwan}",
year = "2016",
month = "11",
day = "16",
doi = "10.1080/10641963.2016.1200599",
language = "English",
volume = "38",
pages = "701--709",
journal = "Clinical and Experimental Hypertension",
issn = "1064-1963",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Factors affecting treatment compliance in new hypertensive patients in Korea

AU - Kim, Hyun Jin

AU - Moon, Kanghee

AU - Park, Tae Hee

AU - Park, So Youn

AU - Yoon, Seok-Jun

AU - Oh, In Hwan

PY - 2016/11/16

Y1 - 2016/11/16

N2 - This study aims to analyze continuity of care according to complications and examine the relationship between the continuity of care and health outcomes (hospitalization, emergency department visits, and complications) using data of new hypertensive patients from Korea’s National Health Insurance Claims database. There were a total of 715,053 new hypertensive patients followed up for three years until 2011. Indices of continuity of care were Continuity of Care Index (COC), Modified, Modified Continuity Index (MMCI), and Most Frequent Provider Continuity (MFPC). The mean values of COC, MMCI, and MFPC were 0.79, 0.77, and 0.87, respectively, in new hypertensive patients with complications, and 0.80, 0.79, and 0.87, respectively, in those without complications. The factors affecting the continuity of care were sex, ambulatory care visits, number of providers, main medical institution, and Charlson’s comorbidity score. Following analysis of the correlation between the treatment compliance and health outcomes, the low COC group had a higher association with hospitalization, the emergency department visit, and complications as compared with the high COC group. COC and medication adherence were associated with a reduction of hospitalization, emergency department visits, and complications. This indicates it would be mandatory to manage the patients’ continuity of care.

AB - This study aims to analyze continuity of care according to complications and examine the relationship between the continuity of care and health outcomes (hospitalization, emergency department visits, and complications) using data of new hypertensive patients from Korea’s National Health Insurance Claims database. There were a total of 715,053 new hypertensive patients followed up for three years until 2011. Indices of continuity of care were Continuity of Care Index (COC), Modified, Modified Continuity Index (MMCI), and Most Frequent Provider Continuity (MFPC). The mean values of COC, MMCI, and MFPC were 0.79, 0.77, and 0.87, respectively, in new hypertensive patients with complications, and 0.80, 0.79, and 0.87, respectively, in those without complications. The factors affecting the continuity of care were sex, ambulatory care visits, number of providers, main medical institution, and Charlson’s comorbidity score. Following analysis of the correlation between the treatment compliance and health outcomes, the low COC group had a higher association with hospitalization, the emergency department visit, and complications as compared with the high COC group. COC and medication adherence were associated with a reduction of hospitalization, emergency department visits, and complications. This indicates it would be mandatory to manage the patients’ continuity of care.

KW - cardio-cerebrovascular diseases

KW - Continuity of care

KW - hypertension

KW - Korea

KW - treatment compliance

UR - http://www.scopus.com/inward/record.url?scp=85004140796&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85004140796&partnerID=8YFLogxK

U2 - 10.1080/10641963.2016.1200599

DO - 10.1080/10641963.2016.1200599

M3 - Article

VL - 38

SP - 701

EP - 709

JO - Clinical and Experimental Hypertension

JF - Clinical and Experimental Hypertension

SN - 1064-1963

IS - 8

ER -